Table 3.
Diuretics used in the treatment of MD’s intercritical phase
| Pharmacological class | Activity | Examples of drugs | Side effects |
|---|---|---|---|
| Thiazides | Inhibit reabsorption of luminal sodium by blocking the Na+/Cl− channel in the kidney’s distal convoluted tubule |
Chlorthalidone Hydrochlorothiazide |
Hypokalemia Hyperuricemia Hyperglycemia |
| Potassium-sparing diuretics | Inhibit renal Na+/K+ exchange | Spironolactone |
Hyperkalemia Hormonal alterations (estrogenic effects) |
| Loop diuretics | Inhibit renal co-transport by blocking the Na+–K+–2Cl− symporter | Furosemide |
Hypovolemia Hypotension Hypokalemia |
| Carbonic anhydrase inhibitors | Inhibit H+ secretion and promote Na+ and K+ excretion | Acetazolamide |
Gastrointestinal disturbances Metabolic acidosis Nephrolithiasis |
MD Ménière’s disease